Serent Capital announced the sale of its portfolio company, Professional Health Care Network (PHCN) to The Vistria Group. PHCN is a home health care management services company that partners with health plans and providers to increase the access and value of home-based clinical care.
The Phoenix-based company is a leading provider of home health management solutions and care coordination throughout the western U.S. Working in collaboration with major health plans and providers, PHCN has demonstrated a proven track record of providing greater access to home health care in the recovery stages, effectively reducing emergent and long-term institutionalization, and above all, improving the satisfaction and health outcomes of PHCN’s over 950,000 supported lives.
Since Serent’s investment in May 2019, PHCN:
- Built out its entire executive team, including adding Brian Sassi as Chief Executive Officer, in addition to a Chief Growth Officer, Chief Operating Officer, Chief Technology Officer and VP Finance
- Materially enhanced its technology stack, migrating back and front office to the cloud
- Expanded its service offering, adding coverage of Medicare Advantage PPO members to its legacy Medicare Advantage HMO and managed Medicaid offerings
- Grew from its home state of Arizona to enter Colorado, New Mexico and Nevada
- Increased its lives covered from 350K to 950K
“PHCN is a fine case study of how Serent’s partnership can help companies to enhance their foundation and thereby drive exceptional growth,” states David Kennedy, Partner Emeritus at Serent Capital. “The impact that Brian and the entire PHCN team have achieved has been truly remarkable. We look forward to seeing their continued success in their next chapter.”
“I have known and admired the Serent team for some time. It was a pleasure to work with them at PHCN, where their partnership was critical in building our strategy and growing our team,” says Brian Sassi, CEO of Professional Health Care Network. “Our ability to triple the lives we serve in such a short time was a testament to the strength of the partnership here between executive team and investor.”
Serent is an active investor in the healthcare market, having invested in over 20 healthcare technology companies in the last 10 years. Recent investments include Raintree System, Procurement Partners, and Hybrent. To learn more about Serent’s partnership with healthcare companies, visit: https://www.serentcapital.com/healthcare/.
This publication is for informational purposes only, and nothing contained herein constitutes an offer to sell or a solicitation of an offer to buy any interest in any investment vehicle managed by Serent Capital or any company in which Serent Capital or its affiliates have invested. An offer or solicitation will be made only through a final private placement memorandum, subscription agreement and other related documents with respect to a particular investment opportunity and will be subject to the terms and conditions contained in such documents, including the qualifications necessary to become an investor. Serent Capital does not utilize its website to provide investment or other advice, and nothing contained herein constitutes a comprehensive or complete statement of the matters discussed or the law relating thereto. Information provided reflects Serent Capital’s views as of a particular time and are subject to change without notice. You should obtain relevant and specific professional advice before making any investment decision.
Executive endorsements of Serent Capital are for illustrative purposes, designed to attract business development contacts, and should not be construed as a client or investor testimonial of Serent Capital's investment advisory services. All such endorsements are from current or former portfolio company leadership about Serent Capital’s ability to provide services to their companies. Certain executives are also investors in Serent Capital’s investment vehicle(s), and as such, there is an inherent conflict in that those executives have an incentive to provide favorable reviews of Serent Capital’s business practices for the benefit of the investment vehicles that they hold a personal ownership interest in. Serent Capital has not, directly or indirectly, paid any compensation to such individuals for their endorsements.
Certain information on this Website may contain forward-looking statements, which are subject to risks and uncertainties and speak only as of the date on which they are made. The words “believe”, “expect”, “anticipate”, “optimistic”, “intend”, “aim”, “will” or similar expressions are intended to identify forward-looking statements. Serent Capital undertakes no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future developments or otherwise. Past performance is not indicative of future results; no representation is being made that any investment or transaction will or is likely to achieve profits or losses similar to those achieved in the past, or that significant losses will be avoided.